![Maio Li Pan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maio Li Pan
Direktor/Vorstandsmitglied bei MingMed Biotechnology Co., Ltd.
Profil
Maio Li Pan is currently a Member-Supervisory Board at MingMed Biotechnology Co., Ltd.
Ms. Pan completed an undergraduate degree from Guangdong University of Technology in 2005.
Aktive Positionen von Maio Li Pan
Unternehmen | Position | Beginn |
---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Direktor/Vorstandsmitglied | 24.06.2022 |
Ausbildung von Maio Li Pan
Guangdong University of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |